ECO Animal Health Group PLC
BLOCK LISTING RETURN
Date: 12 February 2024
| Name of applicant: | ECO Animal Health Group plc | |||
| Name of scheme: | Executive Share Option Scheme and Unapproved Share Option Scheme | |||
| Number and class of securities originally listed and the date of admission: | 1,500,000 ordinary shares of 5 pence each on 20 July 2017 | |||
| Period of return: | From: | 1 November 2022 | To: | 09 February 2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 375,505 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period: | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 375,505
| |||
| | | | | |
-Ends-
For further information please contact:
| |
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
